MyPrurigoTeam

Are you wondering if others are using Nemluvio for prurigo nodularis?

Yes, many people are being treated with Nemluvio (nemolizumab). It was approved by the FDA in 2024 specifically for prurigo nodularis, making it one of only two FDA-approved medications for this condition.

Clinical trials have shown promising results Show Full Answer

Are you wondering if others are using Nemluvio for prurigo nodularis?

Yes, many people are being treated with Nemluvio (nemolizumab). It was approved by the FDA in 2024 specifically for prurigo nodularis, making it one of only two FDA-approved medications for this condition.

Clinical trials have shown promising results. In studies with over 500 people with moderate to severe prurigo nodularis:

- About 58% experienced significant itch relief after 16 weeks
- Nearly 31% achieved total or near-total skin clearance by 24 weeks
- After 2 years of treatment, more than 90% saw at least a four-point drop in itch levels
- Over 70% were itch-free or nearly itch-free at the 2-year mark

Nemluvio is given as a subcutaneous injection once every four weeks. It works by blocking interleukin-31, which triggers itch and inflammation.

The most common side effects reported include headache and types of eczema, and the treatment has been well-tolerated over time with no new safety concerns emerging in longer-term studies.

If you're interested in Nemluvio, talk with your dermatologist about whether it might be right for your situation.

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

58% Saw Itch Relief and 31% Had Skin Clearance From Nemolizumab

90% Have Less Itch After 2 Years on Nemolizumab, Study Finds